Co-Diagnostics, Inc. Common Stock (CODX) Stock Price

CODXStock

$1.21−87.96%52W

Market Cap$8.45M

P/E—

PEG Ratio—

Div yield—

Beta2.92

CODX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-60.09%

Price vs S&P 500 (4W)-19.78%

VGM Score40.22

Book Value / Share (Quarterly)$4.45

P/TBV (Annual)0.77x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-73.70%

Cash Flow / Share (Quarterly)$-8.05

Price vs S&P 500 (YTD)-88.91%

Gross Margin (TTM)45.06%

Net Profit Margin (TTM)-6753.75%

EPS (TTM)$-29.39

10-Day Avg Trading Volume0.42M

EPS Excl Extra (TTM)$-29.39

Revenue Growth (5Y)-61.60%

EPS (Annual)$-35.25

ROI (Annual)-227.33%

Gross Margin (Annual)64.28%

Net Profit Margin (5Y Avg)-1803.56%

Cash / Share (Quarterly)$2.28

Revenue Growth QoQ (YoY)190.27%

ROA (Last FY)-189.54%

Revenue Growth TTM (YoY)-79.47%

EBITD / Share (TTM)$-30.49

ROE (5Y Avg)-64.69%

Operating Margin (TTM)-7053.82%

Cash Flow / Share (Annual)$-14.24

P/B Ratio0.65x

P/B Ratio (Quarterly)0.42x

Net Income / Employee (Annual)$-407,800

EV / Revenue (TTM)2.97x

Net Interest Coverage (TTM)121.11x

ROA (TTM)-141.15%

EV / EBITDA (TTM)0.12x

EPS Incl Extra (Annual)$-35.25

Current Ratio (Annual)3.87x

Quick Ratio (Quarterly)1.94x

3-Month Avg Trading Volume4.12M

52-Week Price Return-87.96%

Revenue / Employee (TTM)$6,200

Tangible BV / Share (Quarterly)$2.45

P/S Ratio (Annual)16.65x

Asset Turnover (Annual)0.03x

52-Week High$46.50

Operating Margin (5Y Avg)-1910.89%

EPS Excl Extra (Annual)$-35.25

CapEx CAGR (5Y)-1.89%

Tangible BV CAGR (5Y)-27.45%

26-Week Price Return-48.16%

Quick Ratio (Annual)3.42x

13-Week Price Return-89.19%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.28x

Enterprise Value$2.13M

Revenue / Share Growth (5Y)-29.37%

Asset Turnover (TTM)0.02x

Book Value / Share Growth (5Y)33.38%

Revenue / Employee (Annual)$5,400

Inventory Turnover (Annual)0.22x

Pretax Margin (Annual)-7793.20%

Cash / Share (Annual)$5.67

3-Month Return Std Dev166.52%

Gross Margin (5Y Avg)69.90%

Net Income / Employee (TTM)$-421,800

ROE (Last FY)-227.33%

Net Interest Coverage (Annual)-2126.85x

EPS Basic Excl Extra (Annual)$-35.25

P/FCF (TTM)0.73x

Receivables Turnover (TTM)6.57x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-29.39

Receivables Turnover (Annual)3.85x

ROI (TTM)-164.92%

P/S Ratio (TTM)14.43x

Pretax Margin (5Y Avg)-1864.20%

Revenue / Share (Annual)$0.47

Tangible BV / Share (Annual)$6.40

Price vs S&P 500 (52W)-106.52%

Year-to-Date Return-76.09%

5-Day Price Return-0.82%

EPS Normalized (Annual)$-35.25

ROA (5Y Avg)-54.90%

Net Profit Margin (Annual)-7533.61%

Month-to-Date Return-15.97%

Cash Flow / Share (TTM)$-1.41

EBITD / Share (Annual)$-36.27

Operating Margin (Annual)-7929.36%

ROI (5Y Avg)-64.69%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-29.39

P/TBV (Quarterly)0.76x

P/B Ratio (Annual)0.50x

Inventory Turnover (TTM)0.41x

Pretax Margin (TTM)-6980.36%

Book Value / Share (Annual)$9.85

Price vs S&P 500 (13W)-91.14%

Beta2.92x

P/FCF (Annual)2.02x

Revenue / Share (TTM)$0.32

ROE (TTM)-164.92%

52-Week Low$0.94

vGradeB

gGradeD

mGradeF

vgmGradeC

CODX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$3.00	-$1.45	+51.63%(+$1.55)
Q1 2026	May 14, 2026	-$3.75	-$4.09	-9.05%(-$0.34)
Q4 2025	Mar 31, 2026	-$3.60	-$4.44	-23.30%(-$0.84)
Q3 2025	Nov 13, 2025	-$5.70	-$4.66	+18.21%(+$1.04)
Q2 2025	Aug 14, 2025	-$7.50	-$7.01	+6.60%(+$0.49)

CODX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.29

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
CODXCo-Diagnostics, Inc. Common Stock	B	D	F	$1.21
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55

About Co-Diagnostics, Inc. Common Stock

Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.